» Articles » PMID: 17234598

The RNA-binding Protein HuD Binds Acetylcholinesterase MRNA in Neurons and Regulates Its Expression After Axotomy

Overview
Journal J Neurosci
Specialty Neurology
Date 2007 Jan 20
PMID 17234598
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

After axotomy, expression of acetylcholinesterase (AChE) is greatly reduced in the superior cervical ganglion (SCG); however, the molecular events involved in this response remain unknown. Here, we first examined AChE mRNA levels in the brain of transgenic mice that overexpress human HuD. Both in situ hybridization and reverse transcription-PCR demonstrated that AChE transcript levels were increased by more than twofold in the hippocampus of HuD transgenic mice. Additionally, direct interaction between the HuD transgene product and AChE mRNA was observed. Next, we examined the role of HuD in regulating AChE expression in intact and axotomized rat SCG neurons. After axotomy of the adult rat SCG neurons, AChE transcript levels decreased by 50 and 85% by the first and fourth day, respectively. In vitro mRNA decay assays indicated that the decrease in AChE mRNA levels resulted from changes in the stability of presynthesized transcripts. A combination of approaches performed using the region that directly encompasses an adenylate and uridylate (AU)-rich element within the AChE 3'-untranslated region demonstrated a decrease in RNA-protein complexes in response to axotomy of the SCG and, specifically, a decrease in HuD binding. After axotomy, HuD transcript and protein levels also decreased. Using a herpes simplex virus construct containing the human HuD sequence to infect SCG neurons in vivo, we found that AChE and GAP-43 mRNA levels were maintained in the SCG after axotomy. Together, the results of this study demonstrate that AChE expression in neurons of the rat SCG is regulated via post-transcriptional mechanisms that involve the AU-rich element and HuD.

Citing Articles

Emerging Roles for the RNA-Binding Protein HuD (ELAVL4) in Nervous System Diseases.

Silvestri B, Mochi M, Garone M, Rosa A Int J Mol Sci. 2022; 23(23).

PMID: 36498933 PMC: 9736382. DOI: 10.3390/ijms232314606.


RNA-binding protein ELAVL4/HuD ameliorates Alzheimer's disease-related molecular changes in human iPSC-derived neurons.

van der Linden R, Gerritsen J, Liao M, Widomska J, Pearse 2nd R, White F Prog Neurobiol. 2022; 217:102316.

PMID: 35843356 PMC: 9912016. DOI: 10.1016/j.pneurobio.2022.102316.


Roles of Embryonic Lethal Abnormal Vision-Like RNA Binding Proteins in Cancer and Beyond.

Cai H, Zheng D, Yao Y, Yang L, Huang X, Wang L Front Cell Dev Biol. 2022; 10:847761.

PMID: 35465324 PMC: 9019298. DOI: 10.3389/fcell.2022.847761.


RNA-Binding Protein HuD as a Versatile Factor in Neuronal and Non-Neuronal Systems.

Jung M, Lee E Biology (Basel). 2021; 10(5).

PMID: 33922479 PMC: 8145660. DOI: 10.3390/biology10050361.


Urokinase-type plasminogen activator (uPA) regulates the expression and function of growth-associated protein 43 (GAP-43) in the synapse.

Merino P, Diaz A, Torre E, Yepes M J Biol Chem. 2019; 295(2):619-630.

PMID: 31819012 PMC: 6956544. DOI: 10.1074/jbc.RA119.010644.


References
1.
Antic D, Lu N, Keene J . ELAV tumor antigen, Hel-N1, increases translation of neurofilament M mRNA and induces formation of neurites in human teratocarcinoma cells. Genes Dev. 1999; 13(4):449-61. PMC: 316478. DOI: 10.1101/gad.13.4.449. View

2.
Ford L, Wilusz J . An in vitro system using HeLa cytoplasmic extracts that reproduces regulated mRNA stability. Methods. 1999; 17(1):21-7. DOI: 10.1006/meth.1998.0703. View

3.
WILSON G, Brewer G . Identification and characterization of proteins binding A + U-rich elements. Methods. 1999; 17(1):74-83. DOI: 10.1006/meth.1998.0709. View

4.
Erondu N, Nwankwo J, Zhong Y, Boes M, Dake B, Bar R . Transcriptional and posttranscriptional regulation of insulin-like growth factor binding protein-3 by cyclic adenosine 3',5'-monophosphate: messenger RNA stabilization is accompanied by decreased binding of a 42-kDa protein to a uridine-rich domain.... Mol Endocrinol. 1999; 13(3):495-504. DOI: 10.1210/mend.13.3.0252. View

5.
Grubic Z, Zajc-Kreft K, Brank M, Mars T, Komel R, Miranda A . Control levels of acetylcholinesterase expression in the mammalian skeletal muscle. Chem Biol Interact. 1999; 119-120:309-19. DOI: 10.1016/s0009-2797(99)00041-1. View